Cargando…
First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation
BACKGROUND: Neurofibromatosis type 2 (NF2) is a rare autosomal dominant nervous system tumor predisposition disorder caused by constitutive inactivation of one of the two copies of NF2. Meningiomas affect about one half of NF2 patients, and are associated with a higher disease burden. Currently, the...
Autores principales: | Dewan, Ramita, Pemov, Alexander, Dutra, Amalia S., Pak, Evgenia D., Edwards, Nancy A., Ray-Chaudhury, Abhik, Hansen, Nancy F., Chandrasekharappa, Settara C., Mullikin, James C., Asthagiri, Ashok R., Heiss, John D., Stewart, Douglas R., Germanwala, Anand V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307647/ https://www.ncbi.nlm.nih.gov/pubmed/28193203 http://dx.doi.org/10.1186/s12885-017-3127-6 |
Ejemplares similares
-
Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas
por: Pemov, Alexander, et al.
Publicado: (2020) -
Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2
por: Montgomery, Blake K., et al.
Publicado: (2016) -
Distinguishing grade I meningioma from higher grade meningiomas without biopsy
por: Varlotto, John, et al.
Publicado: (2015) -
Genomic landscape of high-grade meningiomas
por: Bi, Wenya Linda, et al.
Publicado: (2017) -
A molecularly integrated grade for meningioma
por: Driver, Joseph, et al.
Publicado: (2021)